OT:FDA Panel Calendar
Stocks in the news the next few months..
Date:02/09/2012
Company Name:Astex Pharmaceuticals, Inc.
Ticker:SUPG, ASTX
Drug:Dacogen (sNDA)
Event: FDA panel to review Dacogen in addnl. indication of elderly acute myelogenous leukemia
Date:02/09/2012
Company Name:NeurogesX Inc
Ticker:NGSX
Drug:Qutenza (sNDA)
Event:FDA panel to review Qutenza for addnl indication of HIV-Associated Peripheral Neuropathy
Date:02/14/2012
Company Name:biosante pharmaceuticals inc.
Ticker:BPAX
Drug:Bio-T-Gel (NDA)
Event:FDA decision on Bio-T-Gel for treatment of male hypogonadism or low testosterone levels
Date:02/17/2012
Company Name:Corcept Therapeutics Inc
Ticker:CORT
Drug:Corlux (NDA)
Event:FDA decision on Corlux for treating Cushing’s Syndrome
Date:02/22/2012
Company Name:VIVUS INC
Ticker:VVUS
Drug:Qnexa (NDA resubmission)
Event:FDA panel to review Qnexa for treatmentof obesity
Date:02/23/2012
Company Name:Chelsea Therapeutics International
Ticker:CHTP
Drug:Northera (NDA)
Event:FDA panel review of Northera for treatment of symptomatic neurogenic orthostatic hypotension
Date:02/26/2012
Company Name:Columbia Laboratories Inc
Ticker:CBRX
Drug:PROCHIEVE (NDA)
Event:FDA decision on PROCHIEVE for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy
Date:03/06/2012
Company Name:Discovery Laboratories Inc
Ticker:DSCO
Drug:Surfaxin (NDA Resubmission)
Event:FDA decision on Surfaxin for prevention of respiratory distress syndrome in premature infants
Date:03/06/2012
Company Name:Astex Pharmaceuticals, Inc.
Ticker:SUPG, ASTX
Drug:Dacogen(sNDA)
Event:FDA decision on Dacogen in addnl. indication of elderly Acute Myeloid Leukemia
Date:03/07/2012
Company Name:NeurogesX Inc
Ticker:NGSX
Drug:Qutenza (sNDA)
Event:FDA decision on Qutenza in addnl indication for neuropathic pain associated with HIV-associated peripheral neuropathy
Date:03/08/2012
Company Name:Curis Inc
Ticker:CRIS
Drug:Vismodegib (NDA)
Event:FDA decision on Vismodegib for treatment of advanced Basal Cell Carcinoma
Date:03/26/2012
Company Name:MAP PHARMACEUTICALS,
Ticker:MAPP
Drug:Levadex NDA
Event:FDA decision on Levadex as a potential acute treatment of migraine in adults
Date:03/27/2012
Company Name:AFFYMAX INC
Ticker:AFFY
Drug:Peginesatide (formerly known as Hematide) (NDA)
Event:DA decision on Peginesatide for anemia associated with CKD patients on dialysis
Date:03/28/2012
Company Name:Chelsea Therapeutics International
Ticker:CHTP
Drug:Northera (NDA
Event:FDA decision on Northera for treatment of symptomatic neurogenic orthostatic hypotension
Investor 100
